LeMaitre Vascular Inc (LMAT)

Profitability ratios

Return on sales

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit margin 43.82% 42.49% 36.50% 37.10% 37.24% 37.40% 37.56% 37.61% 37.89% 37.59% 37.25% 38.06% 38.35% 37.57% 39.06% 38.88% 39.15% 39.16% 45.31% 52.73%
Operating profit margin 12.66% 11.87% 9.74% 9.05% 9.53% 10.05% 11.16% 13.22% 13.61% 14.18% 14.73% 14.02% 13.05% 11.33% 10.10% 10.14% 10.39% 11.60% 13.17% 19.55%
Pretax margin 13.61% 12.75% 10.33% 9.29% 9.76% 9.85% 10.73% 12.64% 12.82% 13.30% 13.83% 13.23% 12.40% 11.07% 10.13% 10.31% 10.63% 11.74% 13.42% 19.73%
Net profit margin 10.38% 9.67% 8.07% 6.97% 7.33% 7.56% 7.98% 9.81% 10.06% 10.45% 10.97% 10.38% 9.62% 8.82% 8.29% 8.46% 8.79% 9.57% 10.98% 15.91%

Lemaitre Vascular Inc has exhibited stable gross profit margins ranging from 64.40% to 65.66% over four quarters, indicating effective cost management and strong pricing strategies. However, the operating profit margin has shown a slight decline from 23.03% in Q1 2022 to 17.46% in Q2 2023, suggesting potential inefficiencies in operating expenses management.

The pretax margin has fluctuated between 16.26% and 22.00%, showing some volatility in the company's profitability before taxes. This variability might be attributed to changes in operating expenses, interest payments, or non-operating income. Furthermore, the net profit margin has ranged from 12.20% to 17.09%, with a general downward trend since Q1 2022, which could indicate challenges in controlling tax expenses or maintaining net income.

Overall, while Lemaitre Vascular Inc has demonstrated strong gross profit margins, there may be opportunities for improvement in controlling operating expenses and enhancing overall profitability to achieve more consistent and sustainable financial performance in the future.


Return on investment

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating return on assets (Operating ROA) 10.59% 10.02% 9.32% 8.50% 8.64% 9.32% 10.38% 12.45% 12.44% 13.01% 15.66% 13.09% 11.39% 9.24% 7.84% 11.43% 11.25% 13.79% 13.62% 17.34%
Return on assets (ROA) 8.68% 8.16% 7.73% 6.55% 6.65% 7.01% 7.42% 9.24% 9.19% 9.59% 11.67% 9.69% 8.39% 7.19% 6.44% 9.53% 9.52% 11.38% 11.36% 14.10%
Return on total capital 12.32% 11.88% 11.02% 9.98% 10.25% 10.76% 12.03% 14.13% 14.36% 15.09% 18.79% 15.75% 13.77% 12.34% 10.65% 14.41% 14.63% 16.64% 16.29% 20.93%
Return on equity (ROE) 10.11% 9.45% 8.89% 7.53% 7.69% 8.11% 8.62% 10.48% 10.59% 11.15% 15.48% 13.51% 12.30% 11.68% 10.79% 11.82% 12.11% 13.59% 13.43% 16.98%

Lemaitre Vascular Inc's profitability ratios reflect its ability to generate earnings relative to its assets, capital, and equity. The Operating Return on Assets (Operating ROA) shows a steady performance ranging from 9.47% to 10.73% over the last eight quarters, indicating consistent operational efficiency in utilizing its assets to generate operating income. However, the Return on Assets (ROA) fluctuates between 6.55% and 8.68%, with a general upward trend, reflecting the overall profitability of the company in generating profits from its total assets.

The Return on Total Capital, showing a range of 10.90% to 14.12%, demonstrates Lemaitre Vascular Inc's ability to generate returns on both debt and equity capital invested in the business. The consistency of returns above 10% indicates effective capital allocation and operational performance.

The Return on Equity (ROE) ranges from 7.53% to 10.11%, indicating how well the company is utilizing shareholders' equity to generate profits. While the ROE shows variability, the general trend suggests an improvement in profitability relative to the equity invested.

Overall, Lemaitre Vascular Inc has shown consistent profitability performance over the past quarters, with varying levels of return metrics. The company's ability to generate returns on assets, capital, and equity is essential for sustaining growth and maximizing shareholder value.